Back to Search
Start Over
Supplementary Tables 1-3 from A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Tables 1-3
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3c0bf9a45880b36e2d6a20836105b167
- Full Text :
- https://doi.org/10.1158/1078-0432.22472018